全文获取类型
收费全文 | 5945篇 |
免费 | 318篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 95篇 |
儿科学 | 151篇 |
妇产科学 | 132篇 |
基础医学 | 795篇 |
口腔科学 | 142篇 |
临床医学 | 397篇 |
内科学 | 1589篇 |
皮肤病学 | 123篇 |
神经病学 | 529篇 |
特种医学 | 123篇 |
外科学 | 537篇 |
综合类 | 32篇 |
预防医学 | 528篇 |
眼科学 | 168篇 |
药学 | 446篇 |
中国医学 | 30篇 |
肿瘤学 | 484篇 |
出版年
2023年 | 46篇 |
2022年 | 74篇 |
2021年 | 164篇 |
2020年 | 106篇 |
2019年 | 149篇 |
2018年 | 222篇 |
2017年 | 139篇 |
2016年 | 148篇 |
2015年 | 167篇 |
2014年 | 219篇 |
2013年 | 285篇 |
2012年 | 510篇 |
2011年 | 446篇 |
2010年 | 241篇 |
2009年 | 200篇 |
2008年 | 406篇 |
2007年 | 369篇 |
2006年 | 384篇 |
2005年 | 333篇 |
2004年 | 295篇 |
2003年 | 299篇 |
2002年 | 292篇 |
2001年 | 82篇 |
2000年 | 84篇 |
1999年 | 98篇 |
1998年 | 39篇 |
1997年 | 38篇 |
1996年 | 37篇 |
1995年 | 32篇 |
1994年 | 27篇 |
1993年 | 21篇 |
1992年 | 43篇 |
1991年 | 37篇 |
1990年 | 38篇 |
1989年 | 26篇 |
1988年 | 24篇 |
1987年 | 21篇 |
1986年 | 20篇 |
1985年 | 21篇 |
1984年 | 10篇 |
1983年 | 10篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1977年 | 7篇 |
1975年 | 7篇 |
1968年 | 5篇 |
1966年 | 6篇 |
排序方式: 共有6301条查询结果,搜索用时 46 毫秒
991.
Augustin Coisne Sandro Ninni Jean-Louis Edmé Thomas Modine Stéphanie Mouton Rosario Pilato Hélène Ridon Marjorie Richardson Cedric Klein Staniel Ortmans Claire Seunes Anne-Laure Madika Guillaume Ledieu Mathilde Jacquelinet Bertrand Boutie Alexandre Altes Flavien Vincent Mohamad Koussa David Montaigne 《JACC: Cardiovascular Imaging》2019,12(1):208-210
992.
Manuel Díez Tomás Ratia María José Medrano José María Mugüerza M. Rosario San Román Carlos Medina Ángel Rodríguez María Isabel Sánchez-Seco Cristina Vera Raúl Díaz Pilar Franco Javier Granell 《Cirugía espa?ola》2011,(6):386
Introduction
The relationship between the intra-operative concentration of parathyroid hormone (IOPTH) and the long-term outcome of patients intervened due to primary hyperparathyroidism (PHPT).Patients and methods
A prospective observational study was performed with 120 patients. Three determinations were made of PTH in blood: baseline, when the diseases gland was located, and 10 minutes after its extirpation. The calcium, PTH and vitamin D (25-OH-D3) levels were measured during follow up.Results
A decrease in IOPTH > 50% was observed in 96 (80%) patients, and the post-extirpation value returned to the normal range (Group I), in 18 (15%) a decrease of > 50% but the final value remained higher than normal (Group II) and in 6 (5%) the decrease was < 50% (Group III). Persistent PHPT was detected during follow up in 6 patients (5%): one in Group I (1%), 3 (16.7%) in II and 2 (33.3%) in group III (P < .001). The risk of persistent PHPT was higher in Group II (odds ratio: 19; 95% CI: 1.85-194) and in Group III (odds ratio: 47; 95% CI: 3.53-639). There were no cases of recurrent PHPT. A normal calcium with an increased PTH was detected in 20 patients of Group I (20.8%), 11 (61.1%) in II and 3 (50%) in III (P < .001). These patients had a lower concentration of post-operative vitamin D (17 ng/ml, range: 24; compared to 28 ng/ml, range: 21) (P = .008) and higher frequency of hypovitaminosis D (70.6% compared to 26.2%) (P>.001).Conclusion
The risk of persistent PHPT is higher when the IOPTH decreases more than 50% but still remains high. 相似文献993.
994.
995.
Lander Pea Merino Ricardo Lpez Almaraz Aitor Fernndez de Larrinoa Marta Rubio Lombraa Maria Rosario Gonzlez‐Hermosa 《Pediatric dermatology》2019,36(6):965-966
Multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT) is an extremely rare recently described disorder characterized by diffuse congenital skin and gastrointestinal vascular lesions that may be associated with gastrointestinal bleeding and thrombocytopenia. We herein present a case report of multifocal lymphangioendotheliomatosis without thrombocytopenia or extensive extracutaneous involvement (gastrointestinal bleeding). Given the high morbidity and mortality associated with this disease, it is important for clinicians to recognize this disorder in order to select the most appropriate therapeutic approach. 相似文献
996.
Antonio Montalvo Afonso Fernando Ruiz Juretschke Rosario González Rodrigálvarez Olga Mateo Sierra Begoña Iza Vallejo Roberto García Leal Marc Valera Melé Vicente Casitas Hernando Jose Manuel Hernández Poveda Carlos Fernández Carballal 《Neurocirugía (Asturias, Spain)》2021,32(1):1-9
Background and objectivesThe treatment of deafferentation pain by spinal DREZotomy is a proven therapeutic option in the literature. In recent years, use of DREZotomy has been relegated to second place due to the emergence of neuromodulation therapies. The objectives of this study are to demonstrate that DREZotomy continues to be an effective and safe treatment and to analyse predictive factors for success.Patients and methodsA retrospective study was conducted of all patients treated in our department with spinal DREZotomy from 1998 to 2018. Bulbar DREZotomy procedures were excluded. A visual analogue scale (VAS) and the reduction of routine medication were used as outcome variables. Demographic, clinical and operative variables were analysed as predictive factors for success.ResultsA total of 27 patients (51.9% female) with a mean age of 53.7 years underwent DREZotomy. The main cause of pain was brachial plexus injury (BPI) (55.6%) followed by neoplasms (18.5%). The mean time of pain evolution was 8.4 years with a mean intensity of 8.7 according to the VAS, even though 63% of the patients had previously received neurostimulation therapy. Favourable outcome (≥ 50% pain reduction in the VAS) was observed in 77.8% of patients during the postoperative period and remained in 59.3% of patients after 22 months average follow-up (mean reduction of 4.9 points). This allowed for a reduction in routine analgesic treatment in 70.4% of them. DREZotomy in BPI-related pain presented a significantly higher success rate (93%) than the other pathologies (41.7%) (p = .001). No association was observed between outcome and age, gender, DREZ technique, duration of pain or previous neurostimulation therapies. There were six neurological complications, four post-operative transient neurological deficits and two permanent deficits.ConclusionDorsal root entry zone surgery is effective and safe for treating patients with deafferentation pain, especially after brachial plexus injury. It can be considered an alternative treatment after failed neurostimulation techniques for pain control. However, its indication should be considered as the first therapeutic option after medical therapy failure due to its good long-term results. 相似文献
997.
Rosario Mazzola Giulio Francolini Luca Triggiani Giuseppe Napoli Francesco Cuccia Luca Nicosia Lorenzo Livi Stefano Maria Magrini Matteo Salgarello Filippo Alongi 《Clinical genitourinary cancer》2021,19(3):230-236
BackgroundThe present analysis aims to compare the impact of 18F-fluorocholine (18F-choline) and gallium-68 prostate-specific membrane antigen (68Ga-PSMA) positron emission tomography (PET)-computed tomography (CT)–guided metastases-directed therapies (MDTs) in patients with castration-sensitive oligorecurrent prostate cancer (PC).Materials and MethodsInclusion criteria were: (1) histologically proven prostate adenocarcinoma; (2) evidence of biochemical relapse after primary tumor treatment; (3) ≤ 3 hypermetabolic oligorecurrent lesions detected by 18F-choline or 68Ga-PSMA PET-CT; (4) PET-CT imaging performed in a single nuclear medicine department; (5) patients treated with upfront stereotactic body radiotherapy (SBRT) without hormone therapy; and (6) SBRT delivered with a dose per fraction ≥ 5 Gy. In the case of oligoprogression (≤ 3 lesions outside the previous RT field) after MTD, a further course of SBRT was proposed; otherwise, androgen deprivation therapy (ADT) was administered.ResultsA total of 118 lesions in 88 patients were analyzed. Forty-four (50%) patients underwent 68Ga-PSMA PET-guided SBRT, and the remaining underwent choline PET-based SBRT. The median follow-up was 25 months (range, 5-87 months) for the entire cohort. Overall survival and local control were both 100%. Distant progression occurred in 48 (54.5%) patients, for a median distant progression-free survival of 22.8 months (range, 14.4-28.8 months). The median pre-SBRT prostate-specific antigen was 2.04 ng/mL in the choline PET cohort and 0.58 ng/mL in the PSMA-PET arm. Disease-free survival rates were 63.6% and 34%, respectively, in the 68Ga-PSMA and choline PET group (P = .06). The ADT administration rate was higher after choline-PET–guided SBRT (P = .00) owing to the higher incidence of polymetastatic disease after first-course SBRT compared with 68Ga-PSMA-based SBRT.ConclusionIn the setting of oligorecurrent castration-sensitive PC, PSMA-PET-guided SBRT produced a higher rate of ADT-free patients when compared with the 18F-choline-PET cohort. Randomized trials are advocated. 相似文献
998.
999.
1000.
Yilmaz Hülya Fırtına Sinem Sarıtaş Merve Sayitoğlu Müge Ar Muhlis Cem 《Immunologic research》2022,70(6):811-816
Immunologic Research - Hyper immunoglobulin M (HIGM) syndrome is a rare disorder of the immune system with impaired antibody functions. The clinical picture of the patients varies according to the... 相似文献